MIRA INFORM REPORT

 

 

Report Date :

19.11.2012

 

IDENTIFICATION DETAILS

 

Name :

SWETA PHARMA PRIVATE LIMITED

 

 

Registered Office :

Dalamal House, 4th Floor, Nariman Point, Mumbai – 400 021, Maharashtra

 

 

Country :

India

 

 

Financials (as on) :

31.03.2012

 

 

Date of Incorporation :

19.06.1981

 

 

Com. Reg. No.:

11-024656

 

 

Capital Investment / Paid-up Capital :

Rs.0.222 million

 

 

CIN No.:

[Company Identification No.]

U24239MH1981PTC024656

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Trader of Pharmaceutical Products such as Chemicals, Drugs etc.

 

 

No. of Employees :

9 (Approximately) ( In Office)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

B (32)

 

RATING

STATUS

 

PROPOSED CREDIT LINE

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

Small

 

Maximum Credit Limit :

USD 17000 

 

 

Status :

Moderate

 

 

Payment Behaviour :

Slow but correct

 

 

Litigation :

Clear

 

 

Comments :

Subject is an established company having moderate track. There appears some external borrowings recorded by the company which exceeds the networth.

 

However, trade relations are reported as fair. Business is active. Payments are reported to be slow but correct.

 

The company can be considered for business dealings with some caution.

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – June 30, 2012

 

Country Name

Previous Rating

(31.03.2012)

Current Rating

(30.06.2012)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

INDIAN ECONOMIC OVERVIEW

 

India is developing into an open-market economy, yet traces of its past autarkic policies remain. Economic liberalization, including industrial deregulation, privatization of state-owned enterprises, and reduced controls on foreign trade and investment, began in the early 1990s and has served to accelerate the country's growth, which has averaged more than 7% per year since 1997. India's diverse economy encompasses traditional village farming, modern agriculture, handicrafts, a wide range of modern industries, and a multitude of services. Slightly more than half of the work force is in agriculture, but services are the major source of economic growth, accounting for more than half of India's output, with only one-third of its labor force. India has capitalized on its large educated English-speaking population to become a major exporter of information technology services and software workers. In 2010, the Indian economy rebounded robustly from the global financial crisis - in large part because of strong domestic demand - and growth exceeded 8% year-on-year in real terms. However, India's economic growth in 2011 slowed because of persistently high inflation and interest rates and little progress on economic reforms. High international crude prices have exacerbated the government's fuel subsidy expenditures contributing to a higher fiscal deficit, and a worsening current account deficit. Little economic reform took place in 2011 largely due to corruption scandals that have slowed legislative work. India's medium-term growth outlook is positive due to a young population and corresponding low dependency ratio, healthy savings and investment rates, and increasing integration into the global economy. India has many long-term challenges that it has not yet fully addressed, including widespread poverty, inadequate physical and social infrastructure, limited non-agricultural employment opportunities, scarce access to quality basic and higher education, and accommodating rural-to-urban migration.

Source : CIA

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2012.

 

LOCATIONS

 

Registered Office :

Dalamal House, 4th Floor, Nariman Point, Mumbai – 400 021, Maharashtra, India

Tel. No.:

91-22-22010336

Fax No.:

91-22-22076974

E-Mail :

khimani@amoliindia.com

Area :

1100 sq ft

Location:

Owned

 

 

Corporate Office :

11/12, Mansoor Building, 98, Princess Street, Mumbai – 400 002, Maharashtra, India

Location:

Owned

 

 

DIRECTORS

 

As on 14.09.2012

 

Name :

Mr. Manish Umed Doshi

Designation :

Director

Address :

1202, Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar, Mumbai – 400 006, Maharashtra, India

Date of Birth/Age :

07.10.1961

Date of Appointment :

12.08.1997

DIN No. :

00210389

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24231MH1982PTC224236

UMEDICA LABORATORIES PRIVATE LIMITED

Director

05/01/1982

05/01/1982

-

Active

NO

2

U67120MH1991PTC060393

TOLSTOY INVESTMENTS PRIVATE LIMITED

Director

19/03/1991

19/03/1991

-

Active

NO

3

U24231GJ1991PTC016288

AMOLI ORGANICS PRIVATE LIMITED

Director

15/10/1994

15/10/1994

-

Active

NO

4

U99999MH1958PTC011058

URANUS ELECTRO TECHNIK PRIVATE LIMITED

Director

10/07/1995

10/07/1995

-

Active

NO

5

U24239MH1981PTC024656

SWETA PHARMA PRIVATE LIMITED

Director

12/08/1997

12/08/1997

-

Active

NO

6

U24117GJ1999PTC035456

SUJAG FINE CHEMICALS PRIVATE LIMITED

Director

19/02/1999

19/02/1999

-

Active

NO

7

U24239MH1989PTC051908

AGRIGUARD MANUFACTURING PRIVATE LIMITED

Director

27/12/1999

27/12/1999

-

Active

NO

8

U24231GJ1988PTC010742

BROMOFINE CHEM PRIVATE LIMITED

Director

26/12/2000

26/12/2000

-

Active

NO

9

U72900MH2004PTC144104

AMOLI INFOTECH PRIVATE LIMITED

Director

20/01/2004

20/01/2004

-

Active

NO

10

U51909MH2003PTC142648

KMI BUSINESS TECHNOLOGIES PRIVATE LIMITED

Director

17/08/2004

17/08/2004

-

Active

NO

11

L45200PN1991PLC129428

KOLTE-PATIL DEVELOPERS LIMITED

Director

04/07/2007

26/12/2006

-

Active

NO

12

U67110MH2009PTC191826

AMOLI INVESTMENT SERVICES PRIVATE LIMITED

Director

18/04/2009

18/04/2009

-

Active

NO

13

U70102MH2009PTC191879

AMOLI PROPERTIES PRIVATE LIMITED

Director

21/04/2009

21/04/2009

-

Active

NO

14

U67100MH2009PTC192008

UMEDICA INVESTMENT SERVICES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

-

Active

NO

15

U70102MH2009PTC192006

UMEDICA PROPERTIES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

-

Active

NO

16

U85199PN2005PTC020895

STEMONE BIOLOGICALS PRIVATE LIMITED

Director

26/06/2010

26/06/2010

-

Active

NO

 

 

Name :

Mrs. Vandana Manish Doshi

Designation :

Director

Address :

1202, Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar, Mumbai – 400 006, Maharashtra, India

Date of Birth/Age :

23.08.1962

Date of Appointment :

20.03.1985

DIN No. :

00211618**

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH1981PTC024656

SWETA PHARMA PRIVATE LIMITED

Director

20/03/1985

20/03/1985

-

Active

NO

2

U67120MH1991PTC060393

TOLSTOY INVESTMENTS PRIVATE LIMITED

Director

19/03/1991

19/03/1991

-

Active

NO

3

U24231GJ1991PTC016288

AMOLI ORGANICS PRIVATE LIMITED

Director

19/09/1991

19/09/1991

-

Active

NO

4

U99999MH1978PTC020156

URANUS ELECTRONICS PRIVATE LIMITED

Director

07/03/1996

07/03/1996

-

Active

NO

5

U72900MH2004PTC144104

AMOLI INFOTECH PRIVATE LIMITED

Director

20/01/2004

20/01/2004

-

Active

NO

6

U67190MH2005PTC155528

APE-AAN FINSER PRIVATE LIMITED

Director

22/08/2005

22/08/2005

-

Active

NO

7

U67110MH2009PTC191826

AMOLI INVESTMENT SERVICES PRIVATE LIMITED

Director

18/04/2009

18/04/2009

-

Active

NO

8

U70102MH2009PTC191879

AMOLI PROPERTIES PRIVATE LIMITED

Director

21/04/2009

21/04/2009

-

Active

NO

9

U67100MH2009PTC192008

UMEDICA INVESTMENT SERVICES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

-

Active

NO

10

U70102MH2009PTC192006

UMEDICA PROPERTIES PRIVATE LIMITED

Director

24/04/2009

24/04/2009

-

Active

NO

 

**DIN has been disabled, Form 32 needs to be filed for same.

 

 

Name :

Mr. Bimal Kumar Shantilal Doshi

Designation :

Director

Address :

Chandan Bala Apartments, 4, R.R. Thakkar Marg, Walkeshwar, Mumbai – 400 006, Maharashtra, India

Date of Birth/Age :

24.01.1964

Date of Appointment :

02.09.2003

DIN No. :

00978718

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24239MH1981PTC024656

SWETA PHARMA PRIVATE LIMITED

Director

02/09/2003

02/09/2003

-

Active

NO

2

U24230MH2003PTC142463

NOVO EXCIPIENTS PRIVATE LIMITED

Director

14/06/2011

14/06/2011

-

Active

NO

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 14.09.2012

 

Names of Shareholders

 

 

No. of Shares

Manish U. Doshi HUF

 

100

Vandana M. Doshi

 

1702

Indu Umed Doshi

 

100

Manish U. Doshi

 

100

Sweta U. Doshi

 

5

Amoli Manish Doshi

 

213

Total

 

2220

 

As on 14.09.2012

 

Equity Share Breakup

 

Percentage of Holding

Category

 

 

Directors or relatives of directors

 

100.00

 

 

BUSINESS DETAILS

 

Line of Business :

Trader of Pharmaceutical Products such as Chemicals, Drugs etc.

 

 

 

 

GENERAL INFORMATION

 

No. of Employees :

9 (Approximately) ( In Office)

 

 

Bankers :

Indian Overseas Bank, Merchant Chamber, Ground Floor, Opposite SNDT College, New Marine Lines, Mumbai – 400 020, Maharashtra, India

 

 

Facilities :

Unsecured Loans

31.03.2012

(Rs. in Millions)

31.03.2011

(Rs. in Millions)

LONG TERM BORROWINGS 

 

 

Unsecured Loans – From Directors

5.838

8.568

Other Loans and Advances

1.926

1.590

SHORT TERM BORROWINGS

 

 

Other Loans and Advances

 

 

Indian Overseas Bank

1.274

1.460

Indian Overseas Bank

0.010

0.011

Short Term-Loans and Advances from Related Parties

 

 

Bharat Mercantile Company

0.500

0.500

Mona B. Doshi

0.526

0.023

Sweta U. Doshi

0.112

0.112

Total

10.186

12.264

 

Short Term Borrowings

Note:

Cash Credit facility from Indian Overseas Bank is secured against collateral security of stock and book debts upto 60 days. The facility is also sanctioned against the personal guarantee of both the directors.

 

 

 

Banking Relations :

--

 

 

Auditors :

 

Name :

Pradip Shah and Associates

Chartered Accountants

Address :

F. No.4, Sunbean Chambers, Sir V. Thakersey Marg, Marine Lines, Mumbai – 400 020, Maharashtra, India

Tel. No.:

91-22-66550627/ 0628

Fax No.:

91-22-22091716

Income-tax PAN of auditor or auditor's firm :

AADPS8414P

 

 

Enterprises influenced by Key Management Personnel and their relatives :

v      Bharat Mercantile Company

v      Amoli Organics Private Limited

v      Umedica Laboratories Private Limited

 

 

CAPITAL STRUCTURE

 

As on 31.03.2012

 

Authorised Capital :

No. of Shares

Type

Value

Amount

5000

Equity Shares

Rs.100/- each

Rs.0.500 million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

2220

Equity Shares

Rs.100/-each

Rs.0.222 million

 

 

 

 

 

Reconciliation of shares outstanding at the beginning and at the end of the year:

 

Particulars

31.03.2012

Number of shares

Amount

(Rs. in millions)

At the beginning of the year

2220

0.222

Addition during the year

0

0.000

Deductions during the year

0

0.000

Outstanding at the end of the year

2220

0.222

 

Details of shareholders holding more than 5% shares in the company:

 

Name of Shareholders

As at 31.03.2012

No. of Shares

% of Holding

Vandana M. Doshi

1702

76.67

Amoli M. Doshi

213

9.59


 

FINANCIAL DATA

[all figures are in Rupees Millions]

 

ABRIDGED BALANCE SHEET

 

SOURCES OF FUNDS

 

31.03.2012

31.03.2011

31.03.2010

SHAREHOLDERS FUNDS

 

 

 

1] Share Capital

0.222

0.222

0.222

2] Share Application Money

0.000

0.000

0.000

3] Reserves & Surplus

4.031

2.776

1.492

4] (Accumulated Losses)

0.000

0.000

0.000

NETWORTH

4.253

2.998

1.714

LOAN FUNDS

 

 

 

1] Secured Loans

0.000

0.000

0.000

2] Unsecured Loans

10.186

12.264

11.569

TOTAL BORROWING

10.186

12.264

11.569

DEFERRED TAX LIABILITIES

0.000

0.000

0.000

 

 

 

 

TOTAL

14.439

15.262

13.283

 

 

 

 

APPLICATION OF FUNDS

 

 

 

 

 

 

 

FIXED ASSETS [Net Block]

0.278

0.331

0.352

Capital work-in-progress

0.000

0.000

0.000

 

 

 

 

INVESTMENT

0.010

0.010

0.010

DEFERRED TAX ASSETS

0.012

0.000

0.000

 

 

 

 

CURRENT ASSETS, LOANS & ADVANCES

 

 

 

 

Inventories

11.817
2.682
2.513

 

Sundry Debtors

12.536
6.674
11.837

 

Cash & Bank Balances

0.181
0.257
0.052

 

Other Current Assets

22.746
22.387
0.000

 

Loans & Advances

0.197
0.256
18.741

Total Current Assets

47.477
32.256
33.143

Less : CURRENT LIABILITIES & PROVISIONS

 
 

 

 

Sundry Creditors

29.044
12.574
17.305

 

Other Current Liabilities

0.879
2.379
2.134

 

Provisions

3.415
2.382
0.783

Total Current Liabilities

33.338
17.335
20.222

Net Current Assets

14.139
14.921
12.921

 

 

 

 

MISCELLANEOUS EXPENSES

0.000

0.000

0.000

 

 

 

 

TOTAL

14.439

15.262

13.283

 


PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2012

31.03.2011

31.03.2010

 

SALES

 

 

 

 

 

Sale of Products

24.967

19.433

44.690

 

 

Other Operating Revenue

13.508

6.091

9.334

 

 

Other Income

0.023

0.121

0.058

 

 

TOTAL                                    

38.498

25.645

54.082

 

 

 

 

 

Less

EXPENSES

 

 

 

 

 

Office Expenses

NA

23.759

52.195

 

 

Administrative Expenses

 

 

 

 

 

Advertising Expenses

 

 

 

 

 

TOTAL                                    

NA

23.759

52.195

 

 

 

 

 

 

PROFIT BEFORE TAX

NA

1.886

1.887

 

 

 

 

 

Less

TAX                                                                 

NA

0.602

0.427

 

 

 

 

 

 

PROFIT AFTER TAX                            

1.254

1.284

1.460

 

 

 

 

 

 

EARNINGS IN FOREIGN CURRENCY

 

 

 

 

 

Other Sales

NA

19.433

44.041

 

TOTAL EARNINGS

NA

19.433

44.041

 

 

 

 

 

 

IMPORTS

 

 

 

 

 

Traded Goods

8.020

7.392

NA

 

TOTAL IMPORTS

8.020

7.392

NA

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

564.86

578.38

NA

 

 

KEY RATIOS

 

PARTICULARS

 

 

31.03.2012

31.03.2011

31.03.2010

PAT / Total Income

(%)

3.26

5.01
2.70

 

 

 

 
 

Net Profit Margin

(PBT/Sales)

(%)

NA

9.71

4.22

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

NA

5.79
5.63

 

 

 

 
 

Return on Investment (ROI)

(PBT/Networth)

 

NA

0.63
1.10

 

 

 

 
 

Debt Equity Ratio

(Total Liability/Networth)

 

10.23

9.87
18.55

 

 

 

 
 

Current Ratio

(Current Asset/Current Liability)

 

1.42

1.86
1.64

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Check List by Info Agents

Available in Report (Yes / No)

1) Year of Establishment

Yes

2) Locality of the firm

Yes

3) Constitutions of the firm

Yes

4) Premises details

Yes

5) Type of Business

Yes

6) Line of Business

Yes

7) Promoter’s background

Yes

8) No. of employees

Yes

9) Name of person contacted

No

10) Designation of contact person

No

11) Turnover of firm for last three years

Yes

12) Profitability for last three years

Yes

13) Reasons for variation <> 20%

--

14) Estimation for coming financial year

No

15) Capital in the business

No

16) Details of sister concerns

Yes

17) Major suppliers

No

18) Major customers

No

19) Payments terms

No

20) Export / Import details (if applicable)

No

21) Market information

--

22) Litigations that the firm / promoter involved in

--

23) Banking Details

Yes

24) Banking facility details

Yes

25) Conduct of the banking account

--

26) Buyer visit details

--

27) Financials, if provided

Yes

28) Incorporation details, if applicable

Yes

29) Last accounts filed at ROC

Yes

30) Major Shareholders, if available

Yes

31) Date of Birth of Proprietor/Partner/Director, if available

Yes

32) PAN of Proprietor/Partner/Director, if available

No

33) Voter ID No of Proprietor/Partner/Director, if available

No

34) External Agency Rating, if available

No

 

 


BANKERS CHARGES REPORT AS PER REGISTRY:

 

Corporate identity number of the company

U24239MH1981PTC024656

Name of the company

SWETA PHARMA PRIVATE LIMITED

Address of the registered office or of the principal place of  business in India of the company

Dalamal House, 4th Floor, Nariman Point, Mumbai – 400 021, Maharashtra, India

E-Mail : khimani@amoliindia.com

This form is for

Creation of charge

Type of charge

Book Debts

Movable property (not being pledge)

Particular of charge holder

Indian Overseas Bank, Merchant Chamber, Ground Floor, Opposite SNDT College, New Marine Lines, Mumbai – 400 020, Maharashtra, India

E-Mail: marinbr@mummrc01.iobnet.co.in

Nature of instrument creating charge

Letter of Hypothecation (For securing Machineries/Vehicles/Goods/Book-Debts).

Date of instrument Creating the charge

26.04.2011

Amount secured by the charge

Rs.8.000 Millions

Brief of the principal terms an conditions and extent and operation of the charge

Rate of interest :

Cash Credit: Base Rate + 3.75%.

 

Terms of repayment :

As per Sanction Letter.

 

Margin :

Letter of Credit-Inland and Foreign (DP/DA upto 90 days):- 25%

Sublimit- Clean Cash Credit against Stock and Book Debts (upto 60 days):- 25% on Stock and 50% on Book Debts.

 

Extent and operation of the charge :

Exclusive charge by hypothecation of Documents of title to goods /accepted hundies / stock / Book debts present and future.

 

Others :

Letter of Credit facility of Rs.8.000 millions with sub-limit Clean Cash Credit of Rs.0.500 million.

Short particulars of the property or asset(s) charged (including complete address and location of the property)

Exclusive charge by hypothecation of Documents of title to goods /accepted hundies / stock / Book debts present and future

 

FIXED ASSETS:

 

v      Air Conditioner

v      Motor Car

v      Computer

v      Fax Machine

v      Printer

v      Vehicle

v      Furniture

v      Fingerprint Machine

 


CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No records exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                  None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                          None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                          None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 


 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency

Unit

Indian Rupees

US Dollar

1

Rs.54.99

UK Pound

1

Rs.87.21

Euro

1

Rs.70.22 

 

 

INFORMATION DETAILS

 

Report Prepared by :

SMN

 


 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

4

PAID-UP CAPITAL

1~10

3

OPERATING SCALE

1~10

4

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

4

--PROFITABILIRY

1~10

4

--LIQUIDITY

1~10

3

--LEVERAGE

1~10

3

--RESERVES

1~10

3

--CREDIT LINES

1~10

4

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

TOTAL

 

32

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                 Payment record (10%)

Credit history (10%)                    Market trend (10%)                                Operational size (10%)

 


 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

-

NB

                                       New Business

-

 

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.